ABBV

AbbVie Inc. is a research‑focused biopharmaceutical company that discovers, develops, manufactures and markets prescription medicines and biologics. Its portfolio spans immunology drugs such as Humira, Skyrizi and Rinvoq, oncology therapies including Imbruvica and Venclexta, neuroscience products like Vraylar and migraine treatments, as well as aesthetics brands such as Botox. AbbVie operates in the global pharmaceutical and healthcare sector, emphasizing innovative therapies for complex, chronic diseases. The firm is regarded as a leading U.S. biotech firm, noted for its blockbuster immunology franchise and a growing pipeline across multiple therapeutic areas.